
Europe - FRA:NZM2 - DK0060336014 - Common Stock
The current stock price of NZM2.DE is 54.76 EUR. In the past month the price increased by 1.44%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| GIN.DE | GIVAUDAN-REG | 28.33 | 35.33B | ||
| SIKA.DE | SIKA AG-REG | 23.1 | 30.55B | ||
| DSFIR.AS | DSM-FIRMENICH AG | 80.72 | 20.16B | ||
| BRG.OL | BORREGAARD ASA | 20.9 | 18.56B | ||
| ELK.OL | ELKEM ASA | N/A | 16.82B | ||
| SY1.DE | SYMRISE AG | 22.54 | 11.44B | ||
| 1COV.DE | COVESTRO AG | N/A | 11.25B | ||
| AMC.DE | ALBEMARLE CORP | N/A | 10.64B | ||
| AKZA.AS | AKZO NOBEL N.V. | 20.43 | 10.38B | ||
| SYENS.BR | SYENSQO SA | 19.43 | 7.53B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 9.02 | 7.02B | ||
| NVJP.DE | UMICORE | 15.04 | 4.19B |
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
NOVONESIS (NOVOZYMES) B
Krogshoejvej 36
Bagsvaerd DK
Employees: 10582
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
The current stock price of NZM2.DE is 54.76 EUR. The price decreased by -0.69% in the last trading session.
NOVONESIS (NOVOZYMES) B (NZM2.DE) has a dividend yield of 1.58%. The yearly dividend amount is currently 0.67.
NZM2.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
NZM2.DE stock is listed on the Deutsche Boerse Ag exchange.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NZM2.DE.
NOVONESIS (NOVOZYMES) B (NZM2.DE) will report earnings on 2025-11-06.
ChartMill assigns a technical rating of 4 / 10 to NZM2.DE.
ChartMill assigns a fundamental rating of 4 / 10 to NZM2.DE. NZM2.DE has only an average score on both its financial health and profitability.
Over the last trailing twelve months NZM2.DE reported a non-GAAP Earnings per Share(EPS) of 0.67. The EPS decreased by -54.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.98% | ||
| ROA | 1.86% | ||
| ROE | 2.85% | ||
| Debt/Equity | 0.28 |
For the next year, analysts expect an EPS growth of 41.09% and a revenue growth 5.64% for NZM2.DE